The impact of smoking on adherence to treatment for latent tuberculosis infection

<p>Abstract</p> <p>Background</p> <p>Studies have shown an association between smoking and tuberculosis (TB) infection, disease and TB-related mortality. We hypothesized that smokers with latent tuberculosis infection (LTBI) are less likely to comply with their LTBI tre...

Full description

Bibliographic Details
Main Authors: Steensma Colin, Rocher Isabelle, Lavigne Mélanie, Brassard Paul
Format: Article
Language:English
Published: BMC 2006-03-01
Series:BMC Public Health
Online Access:http://www.biomedcentral.com/1471-2458/6/66
id doaj-d12db13a84ac4e34a0dfd0560a15c05d
record_format Article
spelling doaj-d12db13a84ac4e34a0dfd0560a15c05d2020-11-24T21:36:27ZengBMCBMC Public Health1471-24582006-03-01616610.1186/1471-2458-6-66The impact of smoking on adherence to treatment for latent tuberculosis infectionSteensma ColinRocher IsabelleLavigne MélanieBrassard Paul<p>Abstract</p> <p>Background</p> <p>Studies have shown an association between smoking and tuberculosis (TB) infection, disease and TB-related mortality. We hypothesized that smokers with latent tuberculosis infection (LTBI) are less likely to comply with their LTBI treatment regimen, thus increasing their risk of developing active disease. We thus documented the impact of smoking on adherence to LTBI treatment.</p> <p>Method</p> <p>Between 1998 and 2000, a convenience sample of patients undergoing treatment for LTBI completed a questionnaire on smoking status. Level of adherence to LTBI treatment was tested for associations with socio-demographic profile, and smoking status</p> <p>Results</p> <p>320 patients were recruited, and 302 (94%) completed the questionnaire. Smoking prevalence was 21%. 72% of patients were adherent to LTBI treatment. Women (OR = 2.0; 95% CI: 1.2–3.3) and non-smokers (OR = 1.8; 95% CI: 1.0–3.3) were associated with adherence to LTBI treatment. Only gender was found as an independent predictor of adherence after adjusting for age and smoking status (OR = 1.9; 95% CI: 1.06–3.3).</p> <p>Conclusion</p> <p>Males and smokers need to have extra supervision to ensure compliance with LTBI treatment.</p> http://www.biomedcentral.com/1471-2458/6/66
collection DOAJ
language English
format Article
sources DOAJ
author Steensma Colin
Rocher Isabelle
Lavigne Mélanie
Brassard Paul
spellingShingle Steensma Colin
Rocher Isabelle
Lavigne Mélanie
Brassard Paul
The impact of smoking on adherence to treatment for latent tuberculosis infection
BMC Public Health
author_facet Steensma Colin
Rocher Isabelle
Lavigne Mélanie
Brassard Paul
author_sort Steensma Colin
title The impact of smoking on adherence to treatment for latent tuberculosis infection
title_short The impact of smoking on adherence to treatment for latent tuberculosis infection
title_full The impact of smoking on adherence to treatment for latent tuberculosis infection
title_fullStr The impact of smoking on adherence to treatment for latent tuberculosis infection
title_full_unstemmed The impact of smoking on adherence to treatment for latent tuberculosis infection
title_sort impact of smoking on adherence to treatment for latent tuberculosis infection
publisher BMC
series BMC Public Health
issn 1471-2458
publishDate 2006-03-01
description <p>Abstract</p> <p>Background</p> <p>Studies have shown an association between smoking and tuberculosis (TB) infection, disease and TB-related mortality. We hypothesized that smokers with latent tuberculosis infection (LTBI) are less likely to comply with their LTBI treatment regimen, thus increasing their risk of developing active disease. We thus documented the impact of smoking on adherence to LTBI treatment.</p> <p>Method</p> <p>Between 1998 and 2000, a convenience sample of patients undergoing treatment for LTBI completed a questionnaire on smoking status. Level of adherence to LTBI treatment was tested for associations with socio-demographic profile, and smoking status</p> <p>Results</p> <p>320 patients were recruited, and 302 (94%) completed the questionnaire. Smoking prevalence was 21%. 72% of patients were adherent to LTBI treatment. Women (OR = 2.0; 95% CI: 1.2–3.3) and non-smokers (OR = 1.8; 95% CI: 1.0–3.3) were associated with adherence to LTBI treatment. Only gender was found as an independent predictor of adherence after adjusting for age and smoking status (OR = 1.9; 95% CI: 1.06–3.3).</p> <p>Conclusion</p> <p>Males and smokers need to have extra supervision to ensure compliance with LTBI treatment.</p>
url http://www.biomedcentral.com/1471-2458/6/66
work_keys_str_mv AT steensmacolin theimpactofsmokingonadherencetotreatmentforlatenttuberculosisinfection
AT rocherisabelle theimpactofsmokingonadherencetotreatmentforlatenttuberculosisinfection
AT lavignemelanie theimpactofsmokingonadherencetotreatmentforlatenttuberculosisinfection
AT brassardpaul theimpactofsmokingonadherencetotreatmentforlatenttuberculosisinfection
AT steensmacolin impactofsmokingonadherencetotreatmentforlatenttuberculosisinfection
AT rocherisabelle impactofsmokingonadherencetotreatmentforlatenttuberculosisinfection
AT lavignemelanie impactofsmokingonadherencetotreatmentforlatenttuberculosisinfection
AT brassardpaul impactofsmokingonadherencetotreatmentforlatenttuberculosisinfection
_version_ 1725941108168458240